Your browser doesn't support javascript.
loading
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
Mazzaferro, Vincenzo; El-Rayes, Bassel F; Droz Dit Busset, Michele; Cotsoglou, Christian; Harris, William P; Damjanov, Nevena; Masi, Gianluca; Rimassa, Lorenza; Personeni, Nicola; Braiteh, Fadi; Zagonel, Vittorina; Papadopoulos, Kyriakos P; Hall, Terence; Wang, Yunxia; Schwartz, Brian; Kazakin, Julia; Bhoori, Sherrie; de Braud, Filippo; Shaib, Walid L.
Afiliação
  • Mazzaferro V; Department of Surgery and Oncology, Istituto Nazionale Tumori IRCCS, Milan, Italy. vincenzo.mazzaferro@istitutotumori.mi.it.
  • El-Rayes BF; University of Milan, Milan, Italy. vincenzo.mazzaferro@istitutotumori.mi.it.
  • Droz Dit Busset M; Winship Cancer Institute, Emory University, Atlanta, GA, USA. belraye@emory.edu.
  • Cotsoglou C; Department of Surgery and Oncology, Istituto Nazionale Tumori IRCCS, Milan, Italy.
  • Harris WP; Department of Surgery and Oncology, Istituto Nazionale Tumori IRCCS, Milan, Italy.
  • Damjanov N; Seattle Cancer Care Alliance, Seattle, WA, USA.
  • Masi G; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Rimassa L; Department of Oncology, Pisa University Hospital, Pisa, Italy.
  • Personeni N; Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Braiteh F; Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Zagonel V; Department of Medical Biosciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Papadopoulos KP; Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.
  • Hall T; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Wang Y; South Texas Accelerated Research Therapeutics, San Antonio, TX, USA.
  • Schwartz B; ArQule, Inc, Burlington, MA, USA.
  • Kazakin J; ArQule, Inc, Burlington, MA, USA.
  • Bhoori S; ArQule, Inc, Burlington, MA, USA.
  • de Braud F; ArQule, Inc, Burlington, MA, USA.
  • Shaib WL; Department of Surgery and Oncology, Istituto Nazionale Tumori IRCCS, Milan, Italy.
Br J Cancer ; 120(2): 165-171, 2019 01.
Article em En | MEDLINE | ID: mdl-30420614
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Colangiocarcinoma / Alcaloides / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Colangiocarcinoma / Alcaloides / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article